Understanding Sabia virus infections (Brazilian mammarenavirus)

Imagem de Miniatura
Arquivos
art_NASTRI_Understanding_Sabia_virus_infections_Brazilian_mammarenavirus_2022.PDF (7.55 MB)
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCI LTD
Autores
SOUZA, William Marciel de
Citação
TRAVEL MEDICINE AND INFECTIOUS DISEASE, v.48, article ID 102351, 9p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Only two naturally occurring human Sabi ' a virus (SABV) infections have been reported, and those occurred over 20 years ago. Methods: We diagnosed two new cases of SABV infection using metagenomics in patients thought to have severe yellow fever and described new features of histopathological findings. Results: We characterized clinical manifestations, histopathology and analyzed possible nosocomial transmission. Patients presented with hepatitis, bleeding, neurological alterations and died. We traced twenty-nine hospital contacts and evaluated them clinically and by RT-PCR and neutralizing antibodies. Autopsies uncovered unique features on electron microscopy, such as hepatocyte ""pinewood knot"" lesions. Although previous reports with similar New-World arenavirus had nosocomial transmission, our data did not find any case in contact tracing. Conclusions: Although an apparent by rare, Brazilian mammarenavirus infection is an etiology for acute hemorrhagic fever syndrome. The two fatal cases had peculiar histopathological findings not previously described. The virological diagnosis was possible only by contemporary techniques such as metagenomic assays. We found no subsequent infections when we used serological and molecular tests to evaluate close contacts.
Palavras-chave
Arenaviruses, Viral hemorrhagic fever, Disease transmission
URI
https://observatorio.fm.usp.br/handle/OPI/49234
Referências
  1. Ali A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67685-0
  2. BARRY M, 1995, NEW ENGL J MED, V333, P294, DOI 10.1056/NEJM199508033330505
  3. Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391
  4. Candido DS, 2020, SCIENCE, V369, P1255, DOI 10.1126/science.abd2161
  5. Casadio L, 2020, NEW ENGL J MED, V382, P2059, DOI 10.1056/NEJMc1913036
  6. Centers for Disease Control and Prevention, 2020, REPR HLTH ENT DEPR W
  7. Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P635
  8. CENTRO DE VIGILANCIA EPIDEMIOLOGICA, 2019, SECRETARIA ESTADUAL
  9. Charrel RN, 2003, ANTIVIR RES, V57, P89, DOI 10.1016/S0166-3542(02)00202-4
  10. Childs JE, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00035
  11. Claro IM., 2021, WELLCOME OPEN RES, P62416, DOI 10.12688/wellcomeopenres.17170.1
  12. Claro IM, 2021, EMERG INFECT DIS, V27, P970, DOI 10.3201/eid2703.210038
  13. COIMBRA TLM, 1994, LANCET, V343, P391, DOI 10.1016/S0140-6736(94)91226-2
  14. Coimbra TLM, 2001, VR R, V6, DOI [10.17525/vrrjournal.v6i1.187, DOI 10.17525/VRRJOURNAL.V6I1.187]
  15. Crameri F., Zenodo [data set], P2021, DOI 10.5281/zenodo.5501399
  16. Cunha MD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56650-1
  17. de Oliveira Renata Carvalho, 2022, Lancet Reg Health Am, V8, P100202, DOI 10.1016/j.lana.2022.100202
  18. DEBRITO T, 1992, PATHOL RES PRACT, V188, P177, DOI 10.1016/S0344-0338(11)81176-3
  19. DUARTE MIS, 1992, ULTRASTRUCT PATHOL, V16, P475
  20. Duarte-Neto AN, 2019, HISTOPATHOLOGY, V75, P638, DOI 10.1111/his.13904
  21. Ellwanger JH, 2017, REV SOC BRAS MED TRO, V50, P3, DOI 10.1590/0037-8682-0330-2016
  22. Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
  23. Figueiredo-Mello C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027207
  24. Guerra JM, 2020, APPL IMMUNOHISTO M M, V28, P403, DOI 10.1097/PAI.0000000000000772
  25. Hanzlick RL, 2000, ARCH PATHOL LAB MED, V124, P594
  26. Kallas EG, 2019, LANCET INFECT DIS, V19, P750, DOI 10.1016/S1473-3099(19)30125-2
  27. Lannetta M, 2019, INFECT DIS CLIN N AM, V33, P977, DOI 10.1016/j.idc.2019.08.003
  28. Laporta GZ, 2012, CAD SAUDE PUBLICA, V28, P229, DOI 10.1590/S0102-311X2012000200003
  29. Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
  30. Malta FD, 2020, EMERG INFECT DIS, V26, P1332, DOI 10.3201/eid2606.200099
  31. Naveca FG, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007065
  32. Escalera-Antezana JP, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101589
  33. Patterson M, 2014, CURR OPIN VIROL, V5, P82, DOI 10.1016/j.coviro.2014.02.007
  34. Radoshitzky SR, 2019, J GEN VIROL, V100, P1200, DOI 10.1099/jgv.0.001280
  35. Ramirez AM, 2019, TRAV MED INFECT DIS, V43, DOI [10.1016/j.tmaid.2021.102124.2021, DOI 10.1016/J.TMAID.2021.102124.2021]
  36. Silva-Ramos CR, 2021, TRAVEL MED INFECT DI, V40, DOI 10.1016/j.tmaid.2021.102001
  37. Sarute N, 2017, ANNU REV VIROL, V4, P141, DOI 10.1146/annurev-virology-101416-042001
  38. Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007
  39. Tapia-Ramirez G, 2022, ECOHEALTH, V19, P22, DOI 10.1007/s10393-022-01580-0
  40. Vasconcelos Pedro Fernando Da Costa, 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P521
  41. WEBB PA, 1969, P SOC EXP BIOL MED, V130, P1013, DOI 10.3181/00379727-130-33711
  42. Wilk-da-Silva R, 2022, ACTA TROP, V228, DOI 10.1016/j.actatropica.2022.106333

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - HC/IPq
Carregar mais